Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:21 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 2,940,627 7.700% |
2,940,627 (New Position) |
Filing History |
| 2021-02-16 3:18 pm Sale |
2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
BCLS I Investco, LP | 1,270,003 2.700% |
-1,291,347 (-50.42%) |
Filing History |
| 2021-02-16 3:15 pm Sale |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
BCLS I Investco, LP | 0 0.000% |
-2,575,360 (Position Closed) |
Filing History |
| 2021-02-08 5:00 pm Unchanged |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 3,609,796 7.400% |
0 (Unchanged) |
Filing History |
| 2020-12-14 5:25 pm Sale |
2020-12-10 | 13D | Dicerna Pharmaceuticals, Inc. DRNA |
BCLS I Investco, LP | 2,786,247 3.700% |
-904,556 (-24.51%) |
Filing History |
| 2020-10-27 4:23 pm Purchase |
2020-10-26 | 13D | Aptinyx Inc. APTX |
BCLS I Investco, LP | 8,066,113 13.300% |
3,023,816 (+59.97%) |
Filing History |
| 2020-05-28 5:11 pm Purchase |
2020-05-27 | 13D | Dynavax Technologies Corporation DVAX |
BCLS I Investco, LP | 10,895,773 13.000% |
2,165,066 (+24.80%) |
Filing History |